Get the Stockscreener App
1.29
1.57%
0.02
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
36.13%
5.998
|
4.406 | 5.808 | 8.188 | 9.435 |
| Interest Income/Expense |
187.50%
0.23
|
0.08 | 0.04 | - | - |
| Operating Income/Loss |
36.13%
-5.998
|
-4.406 | -5.808 | -8.188 | -9.435 |
| Nonoperating Income/Loss |
816.22%
-0.53
|
0.074 | -0.254 | -0.529 | -1.604 |
| Income/Loss From Continuing Operations Before Tax |
50.69%
-6.528
|
-4.332 | -6.062 | -8.717 | -11.04 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
50.69%
-6.528
|
-4.332 | -6.062 | -8.717 | -11.04 |
|
Net Income/Loss
|
50.69%
-6.528
|
-4.332 | -6.062 | -8.717 | -11.04 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
437.29%
8.8523
|
1.6476 | 81.95 | 73.22 | 67.45 |
| Diluted Average Shares |
8.8523
|
- | 81.95 | 73.22 | 67.45 |
| Basic Earnings Per Share |
1,380%
-0.74
|
-0.05 | -0.07 | -0.12 | -0.16 |
| Diluted Earnings Per Share |
-0.74
|
- | -0.07 | -0.12 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):